Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Opening day: Long-awaited halal food franchise arrives in KC with more locations on the menu
Osama Hanif was as hungry for an opportunity to prove himself as he was to eat his favorite halal food in Kansas City, he said, reflecting on the years-long process to open an east coast franchise restaurant in the Midwest. “Once I had my first taste of growing a company, I knew I wanted to…
Amplified to scale: Superstars initiative shines brighter as Chamber widens spotlight (Photos)
Editor’s note: The Greater Kansas City Chamber of Commerce is a non-financial partner of Startland News, which serves as the media partner for the Small Business Superstars program. For the roughly 400 entrepreneurs who gathered Wednesday at lightwell, being a small business owner began to feel like something much bigger, said organizers of the KC…
Tamba Hali traded cleats for beats; former Chiefs linebacker’s latest music release runs from the field to the fine arts
Tamba Hali spent his entire 12-year NFL career with Kansas City. Now — as an Afrobeat recording artist — the home of the Chiefs still factors heavily into his career. On Valentine’s Day (and two days after the Chiefs Super Bowl victory), the former Pro Bowl linebacker released his latest music video — “Fine O”…
From exclusive to expansive: What Pipeline’s first hire in three years (and a $3M grant) mean for its efforts to close region’s resource gap
Kansas City — and the world — miss out when the potential contributions of promising entrepreneurs goes untapped, said Don Carter, pointing to Pipeline Pathfinder’s impact on minority, women, and rural-based entrepreneurs. “There are so many people doing so many dope things, so many cool things in the world, but they just aren’t connected to…